Trial Profile
Chronic Intranasal Oxytocin as an Adjunct to Methadone Maintenance Treatment in Patients With Co-occuring Opioid Use Disorder and Cocaine Use: A 2-week Pilot Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Cocaine-related disorders; Opioid-related disorders
- Focus Adverse reactions
- Acronyms COOOL
- 26 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 20 Jul 2014 Planned number of patients changed from 20 to 30 as reported by ClinicalTrials.gov record.
- 12 Jun 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.